The Eleventh Eilat Conference on New Antiepileptic Drugs (AEDs)-EILAT XI, took place in
Eilat, Israel from the 6th to 10th of May 2012. About 100 basic scientists, clinical …

Zebrafish are now widely accepted as a valuable animal model for a number of different
central nervous system (CNS) diseases. They are suitable both for elucidating the origin of …

Summary The Twelfth Eilat Conference on New Antiepileptic Drugs (AEDs)–EILAT XII, took
place in Madrid, Spain from August 31st to September 3rd 2014. About 130 basic scientists …

Valproic acid (VPA) is a well-established anticonvulsant drug discovered serendipitously
and marketed for the treatment of epilepsy, migraine, bipolar disorder and neuropathic pain …

Summary The Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT
XIII) took place in Madrid, Spain, on June 26–29, 2016, and was attended by> 200 …

For over 40 years, the National Institute of Neurological Disorders and Stroke/National
Institutes of Health-funded Anticonvulsant Screening Program has provided a preclinical …

Epilepsy is a common neurological disorder characterized by an initial injury due to stroke,
traumatic brain injury, brain infection, or febrile seizures causing status epilepticus (SE). This …

Abstract The Epilepsy Therapy Screening Program (ETSP), formerly known as the
Anticonvulsant Screening Program (ASP), has played an important role in the preclinical …

Abstract Since 1992, the Eilat Conferences have provided a forum for all stakeholders in the
epilepsy community to appraise the latest data on new antiepileptic drugs and emergency …

Introduction: Epilepsy is one of the most common neurological diseases affecting
approximately 50 million people worldwide. Despite many advances in epilepsy research …